Skip to content

VR to Evaluate Phantom Limb Pain

Intuitively Controlled Virtual Reality to Treat Phantom Limb Pain

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05915065
Enrollment
48
Registered
2023-06-22
Start date
2020-10-01
Completion date
2025-09-30
Last updated
2025-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation at Ankle (Injury), Lower Limb Amputation Below Knee (Injury), Lower Limb Amputation Knee, Phantom Limb Pain, Phantom Limb Syndrome With Pain, Phantom Pain, Phantom Pain Following Amputation of Lower Limb, Phantom Pain Following Amputation of Upper Limb, Phantom Sensation, Upper Limb Amputation Above Elbow (Injury), Upper Limb Amputation at the Hand, Upper Limb Amputation at the Wrist, Upper Limb Amputation Below Elbow (Injury)

Keywords

Virtual Reality, Limb Loss, Amputation, Phantom Pain

Brief summary

The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the research setting and for at-home use by individuals with upper and lower extremity amputation. We hypothesize that the system will improve PLP for individuals with upper or lower extremity amputation, as measured through with various outcome measures and questionnaires.

Detailed description

The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the research setting and for at-home use by individuals with upper and lower extremity limb absence. Phase 1: Complete in-lab or virtual iterative usability and functionality testing of hardware and software components of The Coapt Phantom Limb Pain Management System to ensure readiness for at-home use - COMPLETED Phase 2: A clinical trial of The Coapt Phantom Limb Pain Management System during at-home use. We hypothesize that the system will improve PLP for individuals with upper or lower extremity absence, as measured through various questionnaires. VR systems have been proposed as alternative technologies to treat PLP since they are relatively inexpensive and more readily available. Virtual reality environments allow for real-time control practice utilizing different tasks and games, and have been widely accepted as clinically viable options for administering therapy. Effective PLP treatment methods are needed for individuals with limb absence that can be utilized on an as-needed basis in the home. VR therapy could potentially be an effective treatment for individuals with chronic upper or lower limb PLP.

Interventions

DEVICECoapt Phantom Limb Pain Management System

The PLP-MS consists of (1) an expandable arm/leg cuff with electrode sensors to collect EMG signals from residual limb muscles, (2) an integrated hardware module (the Coapt Complete Control Gen2.5 system) that translates users' EMG signals into game commands, (3) game software for mobile applications, and (4) a secure, HIPAA-compliant cloud-based data storage system for storing and retrieving user data remotely.

Sponsors

Coapt, LLC
CollaboratorINDUSTRY
Shirley Ryan AbilityLab
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

This study will enroll one, non-random group of amputees to participate in 2-4 in person or virtual research visits, participate in a home trial and complete questionnaires pre home trial, at various points during the home trial and upon conclusion of the home trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults over the age of 18 years old * Amputation of the upper or lower limb, including amputation of multiple limbs * English Speaking * Chronic phantom limb pain (at least 6-months duration) * Average phantom limb pain intensity of 4 or greater on a 0-10 numerical rating scale * Average frequency of phantom limb pain episode of at least twice per month. * Residual limb pain of less than 5 on the Numerical Pain Rating Scale * Pain medication use stable for \> 1 month

Exclusion criteria

* Unable to tolerate use of liner or cuff on their residual limb * Skin irritation/wounds on residual limb that would prevent use of the electrode cuff * Significant cognitive deficits or visual impairment that would preclude them from giving informed consent or following instructions during the experiments, or the ability to obtain relevant user feedback. * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Short-form McGill Pain QuestionnaireBaseline score and at the post-treatment assessment at the end of the 8-week interventionThe primary outcome measure in this study is change in the pain rating index (PRI) between the baseline score and at the post-treatment assessment at the end of the 8-week intervention. The PRI is computed as the sum of the scores for all descriptors of the Short Form of the McGill Pain Questionnaire (SF-MPQ).

Secondary

MeasureTime frameDescription
Visual Analogue Scale (VAS)Baseline score and at the post-treatment assessment at the end of the 8-week interventionThe pain VAS is a unidimensional measure of pain intensity, used to record a persons pain progression, or compare pain severity between paints with similar conditions.
Numerical Pain Rating Scale (NPRS)Baseline score and at the post-treatment assessment at the end of the 8-week interventionThe NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain.
Patient-Reported Outcomes Measurement Information Systems (PROMIS)Baseline score and at the post-treatment assessment at the end of the 8-week interventionROMIS® (Patient-Reported Outcomes Measurement Information System®) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults. PROMIS measures can be used with the general population and with individuals living with chronic conditions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026